申请人:Boehringer Ingelheim GmbH
公开号:US03993683A1
公开(公告)日:1976-11-23
Compounds of the formula ##SPC1## Wherein R.sub.1 is hydrogen, fluorine, bromine, methyl, methoxy, methylthio, nitro, cyano or, when A is other than methylene, R.sub.2 is hydrogen, R.sub.3 is carboxyl, m is 2 and n is 0, also chlorine; R.sub.2 is hydrogen or fluorine; R.sub.3 is hydrogen, methyl, hydroxymethyl, carboxyl, (alkoxy of 1 to 6 carbon atoms)-carbonyl, methoxy-(alkoxy of 1 to 6 carbon atoms)-carbonyl, (alkenyloxy of 2 to 6 carbon atoms)-carbonyl, (aralkoxy of 7 to 12 carbon atoms)-carbonyl, phenoxy-carbonyl, pyridylmethoxy-carbonyl, amino-carbonyl, (alkyl of 1 to 3 carbon atoms-amino)-carbonyl, (dialkyl of 1 to 3 carbon atoms-amino)-carbonyl, phenylamino-carbonyl, morpholino-carbonyl, piperidino-carbonyl, thiomorpholino-carbonyl, (1-oxidothiomorpholino)-carbonyl or (1,1-dioxido-thiomorpholino)-carbonyl; A is methylene, (alkyl of 1 to 3 carbon atoms)-methylene, di-(alkyl of 1 to 3 carbon atoms)-methylene, hydroxymethyl-methylene, hydroxymethylene or carbonyl; m is 1 or 2; and n is 0, 1, 2 or 3; And, when R.sub.3 is carboxyl, non-toxic salts thereof formed with an inorganic or organic base. The compounds as well as the salts are useful as antithrombotics, anticholesteremics and anticoagulants.
分子式为##SPC1##的化合物,其中R.sub.1是氢、氟、溴、甲基、甲氧基、甲硫基、硝基、氰基或者当A不是甲基时,R.sub.2是氢,R.sub.3是羧基,m为2,n为0,也可以是氯;R.sub.2是氢或者氟;R.sub.3是氢、甲基、羟甲基、羧基、(1到6个碳原子的烷氧基)-羰基、甲氧-(1到6个碳原子的烷氧基)-羰基、(2到6个碳原子的烯氧基)-羰基、(7到12个碳原子的芳基氧基)-羰基、苯氧基-羰基、吡啶基甲氧基-羰基、氨基-羰基、(1到3个碳原子的烷基-氨基)-羰基、(1到3个碳原子的二烷基-氨基)-羰基、苯基氨基-羰基、吗啉基-羰基、哌啶基-羰基、噻吩吗啉基-羰基、(1-氧代噻吩吗啉)-羰基或者(1,1-二氧代噻吩吗啉)-羰基;A是甲基、(1到3个碳原子的烷基)-甲基、二-(1到3个碳原子的烷基)-甲基、羟甲基-甲基、羟甲基-甲基或者羰基;m为1或者2;n为0、1、2或者3;当R.sub.3是羧基时,可以与无机或有机碱形成无毒盐。这些化合物以及盐在抗血栓、抗胆固醇和抗凝血中有用。